- Home
- SELF vs ESLA Comparison
SELF vs ESLA Comparison
Compare SELF & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SELF
- ESLA
- Stock Information
- Founded
- SELF 1983
- ESLA 2021
- Country
- SELF United States
- ESLA United States
- Employees
- SELF N/A
- ESLA N/A
- Industry
- SELF Real Estate Investment Trusts
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SELF Real Estate
- ESLA Health Care
- Exchange
- SELF Nasdaq
- ESLA Nasdaq
- Market Cap
- SELF 57.0M
- ESLA 48.9M
- IPO Year
- SELF N/A
- ESLA N/A
- Fundamental
- Price
- SELF $5.00
- ESLA $1.26
- Analyst Decision
- SELF
- ESLA Strong Buy
- Analyst Count
- SELF 0
- ESLA 1
- Target Price
- SELF N/A
- ESLA $16.00
- AVG Volume (30 Days)
- SELF 29.9K
- ESLA 115.6K
- Earning Date
- SELF 11-07-2025
- ESLA 11-20-2025
- Dividend Yield
- SELF 5.78%
- ESLA N/A
- EPS Growth
- SELF 9.99
- ESLA N/A
- EPS
- SELF 0.22
- ESLA N/A
- Revenue
- SELF $12,707,884.00
- ESLA N/A
- Revenue This Year
- SELF $2.50
- ESLA N/A
- Revenue Next Year
- SELF $1.46
- ESLA N/A
- P/E Ratio
- SELF $22.82
- ESLA N/A
- Revenue Growth
- SELF 4.08
- ESLA N/A
- 52 Week Low
- SELF $4.78
- ESLA $0.63
- 52 Week High
- SELF $5.89
- ESLA $1.78
- Technical
- Relative Strength Index (RSI)
- SELF 42.00
- ESLA 54.90
- Support Level
- SELF $4.94
- ESLA $1.12
- Resistance Level
- SELF $5.10
- ESLA $1.48
- Average True Range (ATR)
- SELF 0.07
- ESLA 0.13
- MACD
- SELF 0.00
- ESLA 0.01
- Stochastic Oscillator
- SELF 27.74
- ESLA 31.82
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.